Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Blood|May 23, 2001
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek, M A Dawson, B Storer, et al.
Blood|December 12, 2001
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantationJ Storek, A Joseph, G Espino, et al.
Bone Marrow Transplantation|October 9, 2007
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphomaR N Pham, T A Gooley, G E Keeney, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Bone Marrow Transplantation|December 3, 2003
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationJ Storek, M A Dawson, L C-L Lim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 1998
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's diseaseK Schiffman, C D Buckner, R Maziarz, et al.
Frontiers in Bioscience : a Journal and Virtual Library|August 7, 2001
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st centuryM Maris, A Woolfrey, P A McSweeney, et al.
Blood|October 6, 1997
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphomaD G Maloney, A J Grillo-López, C A White, et al.
Bone Marrow Transplantation|September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCTW I Bensinger, P S Becker, T A Gooley, et al.
Leukemia|April 1, 2005
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CMLF R Kerbauy, R Storb, U Hegenbart, et al.
Pageof 12